Drive Therapeutics
Drive Therapeutics is a preclinical stage company developing a long-lasting bispecific aptamer for retinal diseases.
Alert Banner
Alert:Watch the Boston Globe Today’s video on why North Carolina is an attractive place to grow a life sciences business, including lower business costs and highly skilled workforce.
Close Search Window
